Announcements Trials

Browse Landscape

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Cisplatin 352 Oxaliplatin 262 Capecitabine 258 Radiotherapy 240 Gemcitabine 224 Docetaxel 223 Carboplatin 223 Cyclophosphamide 219 Drug Therapy 218 Paclitaxel 205 apatinib 201 Bevacizumab 194 camrelizumab 190 Fluorouracil 187 sintilimab 133 Blood Specimen Collection 125 Irinotecan 124 Dexamethasone 123 Etoposide 119 toripalimab 118 Radiosurgery 117 Surgical Procedures, Operative 115 pembrolizumab 110 Pemetrexed 108 S 1 (combination) 105 anlotinib 104 Surveys and Questionnaires 101 Leucovorin 101 Nivolumab 98 tislelizumab 96

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × OTHER × Blood Donation × Clear all

NCT04060589 2023-03-22

ReIMAGINE Prostate Cancer Risk

University College, London

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡